Generic Artesunate And Sulphadoxine & Pyrimethamine Tablets

Artesunate + Sulphadoxine & Pyrimethamine Tablets might not be readily available. However, here are some prominent national and international pharmaceutical brands that are known for producing antimalarial drugs, including combinations like Artesunate + Sulphadoxine & Pyrimethamine Tablets:

1. Coartem (Novartis) – International
2. Fansidar (Roche) – International
3. Metakelfin (Sanofi) – International
4. Malaxin (Sun Pharmaceutical Industries Ltd.) – National (India)
5. Artodox (Dr. Reddy’s Laboratories Ltd.) – National (India)
6. Artefan (Ajanta Pharma Limited) – National (India)
7. Duo-Cotecxin (Beijing Holley-Cotec Pharmaceuticals Co., Ltd.) – National (China)
8. Artenam (Ipca Laboratories Ltd.) – National (India)
9. Artegen (Zydus Cadila Healthcare Ltd.) – National (India)
10. Artesun (Cipla Ltd.) – National (India)
11. Artecom (Vivimed Labs Limited) – National (India)
12. A-SP (FDC Limited) – National (India)
13. Dhapar (Syncom Healthcare Limited) – National (India)
14. Artex (Lupin Limited) – National (India)
15. Arteve (Verve Healthcare Ltd.) – National (India)
16. Supranate (Neimeth International Pharmaceuticals Plc.) – National (Nigeria)
17. Arteb (Biolab Sanus Farmacêutica Ltda) – National (Brazil)
18. Malasud (Sudarshan Chemical Industries Limited) – National (India)
19. Arinat (Micro Labs Ltd.) – National (India)
20. Artomal (Mankind Pharma Ltd.) – National (India)
21. Artetop (Biogen Pharma) – National (India)
22. D-Art (Themis Medicare Limited) – National (India)
23. Malarid (Jenburkt Pharmaceuticals Limited) – National (India)
24. Artedom (Medochemie) – International
25. Artinex (Drugfield Pharmaceuticals Limited) – National (Nigeria)
26. Malariazine (Macleods Pharmaceuticals Limited) – National (India)
27. Malact (Acme Laboratories Ltd.) – National (Bangladesh)
28. Artec (Ind-Swift Laboratories Ltd.) – National (India)
29. Artech (Square Pharmaceuticals Ltd.) – National (Bangladesh)
30. Artuvan (Unison Pharmaceuticals Pvt. Ltd.) – National (India)

These brands represent a mix of international and national companies known for producing antimalarial medications. However, please note that the availability and prominence of these brands may vary depending on the region and market dynamics. For the most accurate and up-to-date information, it’s recommended to consult with healthcare professionals or refer to local pharmaceutical databases.

As of my last update, specific rankings of brands for Artesunate + Sulphadoxine & Pyrimethamine Tablets might not be readily available. However, here are some pharmaceutical companies that are known for producing antimalarial drugs, including combinations like Artesunate + Sulphadoxine & Pyrimethamine Tablets. These companies are recognized for their quality and contribution to global healthcare:

1. Novartis (Switzerland)
2. GlaxoSmithKline (United Kingdom)
3. Sanofi (France)
4. Pfizer Inc. (United States)
5. Bayer AG (Germany)
6. Merck & Co., Inc. (United States)
7. Roche (Switzerland)
8. Johnson & Johnson (United States)
9. Sun Pharmaceutical Industries Ltd. (India)
10. Lupin Limited (India)
11. Cipla Ltd. (India)
12. Reddy’s Laboratories Ltd. (India)
13. AstraZeneca (United Kingdom)
14. Teva Pharmaceutical Industries Ltd. (Israel)
15. Abbott Laboratories (United States)
16. Mylan N.V. (United States)
17. Eli Lilly and Company (United States)
18. Takeda Pharmaceutical Company Limited (Japan)
19. Bristol Myers Squibb (United States)
20. Boehringer Ingelheim (Germany)
21. Astellas Pharma Inc. (Japan)
22. Daiichi Sankyo (Japan)
23. Sandoz International GmbH (Switzerland)
24. Aspen Pharmacare Holdings (South Africa)
25. Torrent Pharmaceuticals Ltd. (India)
26. Hikma Pharmaceuticals (Jordan)
27. Ajanta Pharma Limited (India)
28. Biogen (United States)
29. Eisai Co., Ltd. (Japan)
30. Mitsubishi Tanabe Pharma Corporation (Japan)

These companies have a global presence and are often involved in producing and distributing essential medications, including those for malaria treatment. For specific brand rankings, market dynamics might have changed since my last update, and you might need to refer to more recent sources or industry reports.